Acurx Pharmaceuticals holds annual shareholder meeting

ACXP•2026-10-16

Acurx Pharmaceuticals shareholders elected David P. Luci and Jack H. Dean as directors at the October 16, 2026 annual meeting and ratified CohnReznick as the company’s independent registered public accounting firm for fiscal 2026.

Acurx Pharmaceuticals holds annual shareholder meeting

1. Meeting results

Related News

Nvidia CEO reportedly says AI market turmoil will pass

Actinium Pharmaceuticals grants equity awards to new CFO, business development chief

Regal Rexnord credits Kevin Long with 12 restricted stock units from dividend reinvestment

Sources

Acurx Pharmaceuticals holds annual shareholder meeting

CID Holdco agrees to settle $368,107.25 in executive debt with shares and cash

Sensient Technologies announces third-quarter earnings call